Found: 11
Select item for more details and to access through your institution.
Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease–modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 4, p. 693, doi. 10.1093/mr/road066
- By:
- Publication type:
- Article
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 2, p. 322, doi. 10.1093/mr/road020
- By:
- Publication type:
- Article
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 4, p. 715, doi. 10.1093/mr/roac085
- By:
- Publication type:
- Article
Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 5, p. 875, doi. 10.1093/mr/roab082
- By:
- Publication type:
- Article
Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 4, p. 675, doi. 10.1093/mr/roab067
- By:
- Publication type:
- Article
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 3, p. 522, doi. 10.1093/mr/roab026
- By:
- Publication type:
- Article
Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 4, p. 790, doi. 10.1080/14397595.2021.1883252
- By:
- Publication type:
- Article
Risk factors for arthropathy in patients with ulcerative colitis after total colectomy.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 2, p. 468, doi. 10.1080/14397595.2020.1754323
- By:
- Publication type:
- Article
Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort.
- Published in:
- Rheumatology, 2024, v. 63, n. 4, p. 1022, doi. 10.1093/rheumatology/kead317
- By:
- Publication type:
- Article
Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277566
- By:
- Publication type:
- Article
Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibodyassociated vasculitis.
- Published in:
- BMC Immunology, 2017, v. 18, p. 1, doi. 10.1186/s12865-017-0234-8
- By:
- Publication type:
- Article